A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment
Conditions: Breast Cancer Interventions: Drug: First-line Ribociclib + endocrine therapy; Drug: First-line endocrine therapy; Drug: First-line chemtherapy Sponsors: Novartis Pharmaceuticals Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
Conditions: Non-small Cell Lung Cancer; Older People; Carbon Ion Radiotherapy; Radiotherapy Side Effect Interventions: Radiation: carbon ion radiotherapy; Other: targeted therapy; Other: single regimen chemotherapy in sequence with radiotherapy Sponsors: Jian Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
Conditions: Intrahepatic Cholangiocarcinoma; Chemotherapy Effect Interventions: Drug: Floxuridine; Procedure: Selective Internal Radiation Therapy (SIRT) Sponsors: Oslo University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Radiotherapy; Complications; IMMUNOTHERAPY Interventions: Radiation: de-escalated radiotherapy; Radiation: conventional radiotherapy Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Conditions: Thymus Epithelial Tumor; Proton Radiotherapy; Radiation Toxicity Interventions: Radiation: Proton radiotherapy; Other: combined platinum based chemotherapy Sponsors: Jian Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
Conditions: Gastric Cancer; Esophagogastric Junction Cancer Interventions: Drug: Cadonilimab; Drug: Oxaliplatin; Drug: Capecitabine Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.
Conditions: Peripheral Neuropathy Due to Chemotherapy Sponsors: Texas Woman ' s University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy
Conditions: NSCLC Stage IV Interventions: Radiation: SBRT or LDRT; Drug: PD-1/PD-L1 inhibitor combined with platinum-based chemotherapy Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Colorectal Cancer Dataset in Xijing Hospital From 2011
Conditions: Prognostic Cancer Model; Chemotherapy; Nutrition Related Cancer Sponsors: Xijing Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Conditions: Cancer; Solid Tumor; Colorectal Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Targeted Therapy; Chemotherapy; Immunotherapy; Precision Therapy Interventions: Genetic: SNP; Drug: Palbociclib 125mg; Drug: Bevacizumab Sponsors: Lebanese University; Haykel Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.
Conditions: Extensive-stage Small-cell Lung Cancer Interventions: Drug: adebrelimab; Drug: famitinib; Drug: chemotherapy Sponsors: Harbin Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver Metastasis
Conditions: Pancreatic Cancer Interventions: Device: Multi-mode thermal ablation device; Drug: Intravenous anti-PD-1 and chemotherapy Sponsors: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Cancer Interventions: Drug: Combination of pembrolizumab and platinum containing dual drugs Sponsors: Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab
Conditions: Rectal Cancer Interventions: Drug: Camrelizumab; Drug: Chemotherapy; Radiation: Radiotherapy Sponsors: Harbin Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: BL-B01D1; Drug: Irinotecan; Drug: paclitaxel; Drug: docetaxel Sponsors: Sichuan Baili Pharmaceutical Co., Ltd.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
